The aim of this study was to determine the expression of cyclin A and describe its distribution in biopsy samples taken from children with suspected and confirmed celiac disease as well as in control samples. Investigated material consisted of 37 intestinal biopsies: 19 taken from patients with confirmed celiac disease, 9 from patients with its suspicion and 9 from healthy patients, who served as control. Immunohistochemical and immunogold methods were used to estimate cyclin A expression. In celiac disease samples morphological changes in epithelial cells, typical for disease, were shown. We observed weaker cyclin A expression, however there were also some cells with strong labeling in cytoplasm, near the nucleus. In control and suspected celiac disease groups cyclin A was present in the brush border, nucleus and whole cytoplasm, especially in proximity to the nucleus. In conclusion, these studies enabled us visualized pattern of distribution of cyclin A but let us also to presume that observed decrease of expression and its distribution might function as additional factor which could be taken under consideration to establish terminal diagnosis. We are aware of the fact that these are very first observations and that this subject needs to be further investigated with the use of additional methods and samples.
Download full-text PDF |
Source |
---|
Am J Gastroenterol
January 2025
Department of Internal Medicine and Medical Therapeutics, University of Pavia, Italy.
Introduction: Long-term prognosis of non-celiac enteropathies (NCEs) is poorly understood. We aimed to evaluate long-term outcomes and develop a prognostic score for NCEs.
Methods: NCEs patients from an international multicenter cohort (4 Italian centers,1 UK, 1 French,1 Norwegian,1 USA,1 Indian) followed-up over 30 years were enrolled.
Nat Rev Gastroenterol Hepatol
January 2025
Takeda Pharmaceuticals, Cambridge, MA, USA.
Coeliac disease is an autoimmune disease characterized by small intestinal villus atrophy and inflammation upon exposure to gluten. It has a global prevalence of approximately 1%. Although the gluten-free diet can be an effective treatment, this diet is burdensome with practical difficulties and frequent inadvertent gluten exposure.
View Article and Find Full Text PDFAm J Reprod Immunol
February 2025
Department of Gynecology and Obstetrics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Background: Observational studies suggested celiac disease (CD) possibly be a risk factor for premature ovarian failure (POF). However, causality remains unclear. And hypothyroidism and systemic lupus erythematosus may be the mediating factors.
View Article and Find Full Text PDFJ Hum Nutr Diet
February 2025
School of Life and Health Sciences, University of Roehampton, London, UK.
Introduction: A gluten-free (GF) diet, the only treatment for people living with coeliac disease (CD), is challenging, and international guidelines highlight the valuable role of healthcare professionals in enabling self-management. The study aimed to explore the acceptability of telephone and online video consultations for adults with CD.
Methods: A cross-sectional study consisting of an online and paper survey was promoted to adults with CD.
J Imaging Inform Med
January 2025
Department of Radiation Oncology, Henry Ford Health, Detroit, MI, USA.
Automatic segmentation of angiographic structures can aid in assessing vascular disease. While recent deep learning models promise automation, they lack validation on interventional angiographic data. This study investigates the feasibility of angiographic segmentation using in-context learning with the UniverSeg model, which is a cross-learning segmentation model that lacks inherent angiographic training.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!